Log in to save to my catalogue

Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity

Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6435560

Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity

About this item

Full title

Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity

Publisher

England: Portland Press Ltd

Journal title

Bioscience reports, 2018-12, Vol.38 (6)

Language

English

Formats

Publication information

Publisher

England: Portland Press Ltd

More information

Scope and Contents

Contents

Nephrotoxicity is a major toxic effect in chemotherapy, which constitutes up to 60% of hospitalized acute kidney injury (AKI). Very few treatment options exist to slow the transition from AKI to subsequent chronic kidney diseases (CKD). Here, we demonstrate that galectin-3 (Gal-3), a β-galactoside binding lectin that plays an important role in kidn...

Alternative Titles

Full title

Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6435560

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6435560

Other Identifiers

ISSN

0144-8463

E-ISSN

1573-4935

DOI

10.1042/BSR20181803

How to access this item